Skip to main content
. 2022 May 16;42(2):126–139. doi: 10.14639/0392-100X-N1601

VA.

T site other than glottic larynx.

LRFS DSS OS DFS
HR p 95% CI HR p 95% CI HR p 95% CI HR p 95% CI
Nearest microscopic margin on the specimen (mm) as continuous 0.82* 0.057 0.68-1.00
Frankly infiltrated margin HE sect 2.26** 0.043 1.02-4.96
Grading (continuous) 1.65^ 0.008 1.14-2.40
TNM stage (III-IV vs I-II) 2.79^ 0.009 1.29-6.00
pT (classes 3-4 vs classes 1-2) 2.43** 0.017 1.17-5.07 1.91^ 0.035 1.05-3.48 1.80° 0.054 0.99-3.27
Pathologic lymph nodes with ECS (at least 1 vs none) 2.3* 0.039 1.04-5.08 2.07** 0.046 1.01-4.24 2.03° 0.019 1.12-3.66

* Adjusted by: previous treatment, fresh specimen evaluation, nearest microscopic margin on the specimen, grading, lymphovascular invasion, perineural invasion, cT, pT.

** Adjusted by: previous treatment, nearest microscopic margin on the specimen, depth of invasion, grading, lymphovascular invasion, perineural invasion, cT, cN, pN, identified lymph nodes, chemotherapy.

^ Adjusted by: depth of invasion, frankly infiltrated margin HE, nearest microscopic margin on the specimen, lymphovascular invasion, perineural invasion, cT, cN, pN, identified lymph nodes, pathologic lymph nodes with ECS.

° Adjusted by: previous treatment, frankly infiltrated margin HE, nearest microscopic margin on the specimen, grading, lymphovascular invasion, perineural invasion, TNM stage, pN, identified lymph nodes, number of pathological lymph nodes.